Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02983604 |
| Title | GS-5829 in Combination With Fulvestrant or Exemestane in Women With Advanced Estrogen Receptor Positive, HER2 Negative-Breast Cancer |
| Recruitment | Terminated |
| Gender | female |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Gilead Sciences |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Stanford Women's Cancer Center | Stanford | California | 94305 | United States | Details | |
| Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
| Allina Health, Virginia Piper Cancer Institute | Minneapolis | Minnesota | 55407 | United States | Details | |
| The Sarah Cannon Research Institute | Nashville | Tennessee | 37203 | United States | Details | |
| Baylor University Medical Center | Houston | Texas | 77030 | United States | Details | |
| Medical Oncology Associates, PS (dba Summit Cancer Centers) | Spokane | Washington | 99208 | United States | Details |